ESC 365 - Recent data and future direction on dual antiplatelet therapy in patients with diabetes

ESC Premium Access

Recent data and future direction on dual antiplatelet therapy in patients with diabetes

Session: Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)

Topic: Treatment

Speaker: Professor P. Steg (Paris, FR)

Supported by an unrestricted educational grant from AstraZeneca

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

66 presentations

10 followers

5 more presentations in this session

Welcome and introduction

Speaker: Professor P. Steg (Paris, FR)

The prothrombotic nature of diabetes

Speaker: Professor K. Ray (London, GB)

Current practice of dual antiplatelet therapy in patients with diabetes

Speaker: Professor H. Darius (Berlin, DE)

Discussion

Speaker: Doctor M. Bonaca (Aurora, US) Professor H. Darius (Berlin, DE) Professor K. Ray (London, GB) Professor P. Steg (Paris, FR)

Summary and close

Speaker: Doctor M. Bonaca (Aurora, US)

Access the full session

Confronting cardiovascular risk in patients with diabetes - Spotlight on dual antiplatelet therapy (EBAC Accredited)

Speakers: Professor P. Steg, Professor P. Steg, Professor K. Ray, Professor H. Darius, Doctor M. Bonaca...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources